Company page
Remegen Co. Ltd. Class A
Remegen Co. Ltd. Class A, trading under the ticker 688331, is a public company based in China with a market capitalization of approximately 7.33 billion USD. The company is involved in the biopharmaceutical sector, focusing on the development and commercialization of innovative therapies. Remegen is committed to advancing healthcare solutions and improving patient outcomes through its research and development efforts.
- Ticker
- 688331:SSE
- Asset type
- Stock
- Market cap
- $7.33B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- SSE
- Currency
- CNY